J&J pharma leader to retire; Krystal slumps on gene therapy miss
Source: BioPharma Dive - Latest News
Jennifer Taubert will step down after a lengthy run leading J&J’s pharmaceutical business. Elsewhere, pricing issues hampered what Wall Street analysts view as an otherwise strong gene therapy launch.